Schafer Klaus has filed 4 insider transactions across 1 company since September 2023.
Most recent transaction: a grant/award of 48800 shares of Altimmune, Inc. ($ALT) on May 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1, 2026 | Altimmune, Inc. | $ALT | Schafer Klaus | Not found | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 88,104,132 | 9999.99% | 0.06% |
| Sept. 25, 2025 | Altimmune, Inc. | $ALT | Schafer Klaus | Director | A | Stock Options (option to buy) | 48800 | $0.00 | 48,800.0000 | 81,477,548 | 9999.99% | 0.06% |
| Sept. 26, 2024 | Altimmune, Inc. | $ALT | Schafer Klaus | Director | A | Stock Options (option to buy) | 34900 | $0.00 | 34,900.0000 | 70,924,371 | 9999.99% | 0.05% |
| Sept. 28, 2023 | Altimmune, Inc. | $ALT | Schafer Klaus | Director | A | Stock Options (option to buy) | 26100 | $0.00 | 26,100.0000 | 50,691,558 | 9999.99% | 0.05% |